At4g34480 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At4g34480 antibody; T4L20.60Glucan endo-1,3-beta-glucosidase 7 antibody; EC 3.2.1.39; antibody; 1->3)-beta-glucan endohydrolase 7; antibody; 1->3)-beta-glucanase 7 antibody; Beta-1,3-endoglucanase 7 antibody; Beta-1,3-glucanase 7 antibody
Target Names
At4g34480
Uniprot No.

Target Background

Database Links

KEGG: ath:AT4G34480

STRING: 3702.AT4G34480.1

UniGene: At.48072

Protein Families
Glycosyl hydrolase 17 family
Subcellular Location
Secreted. Secreted, cell wall.

Q&A

What detection methods can be used with AT4G33480 antibodies?

AT4G33480 antibodies can be employed in multiple detection methodologies commonly used in plant molecular biology research:

  • Western Blotting (WB): Recommended dilution typically ranges from 1:1000 to 1:8000 depending on antibody sensitivity and optimization

  • Immunofluorescence (IF): Typically used at dilutions around 1:600

  • Chromatin Immunoprecipitation (ChIP): Often requires approximately 6 µg of antibody per experiment

  • Immunoprecipitation (IP): Generally effective at dilutions of 1:100

  • ELISA: Can be performed at dilutions of approximately 1:8000
    Selection of the appropriate method should be based on your specific research question and available equipment.

How can I validate the specificity of an AT4G33480 antibody?

Validating antibody specificity is crucial before proceeding with experiments. Consider these approaches:

  • Western blot analysis with wild-type and mutant/knockout samples

  • Immunoprecipitation followed by mass spectrometry (IP-MS) to identify captured proteins

  • Pre-absorption with blocking peptides to demonstrate specific binding

  • Cross-reactivity testing against related proteins or species
    For example, researchers validated anti-HTA9 antibody specificity using wild-type and hta9, hta11 double mutant Arabidopsis samples, confirming specific detection patterns that corresponded to the expected protein presence or absence . Similar approaches could be applied to AT4G33480 antibody validation.

What controls should be included when performing immunodetection with AT4G33480 antibody?

A robust experimental design should include these controls:

Control TypePurposeImplementation
Positive controlConfirms antibody functionalityUse samples known to express AT4G33480
Negative controlAssesses background/non-specific bindingUse knockout/mutant lines or tissues that don't express the target
Loading controlEnsures equal sample loadingInclude antibodies against housekeeping proteins (e.g., actin, tubulin)
Secondary antibody controlEvaluates non-specific binding of secondary antibodyOmit primary antibody but include secondary antibody
Blocking peptideConfirms specificityPre-incubate antibody with synthetic peptide used as immunogen
These controls help distinguish true signals from artifacts and are essential for publication-quality data .

How can I optimize protein extraction for detection of AT4G33480 in plant tissues?

Optimizing protein extraction is crucial for successful detection:

  • Buffer selection: For Arabidopsis proteins, use a buffer optimized for plant tissues that contains appropriate detergents and protease inhibitors. Commercial extraction buffers specifically designed for plant tissues are available .

  • Tissue disruption: Ensure complete homogenization of plant material, typically using mechanical disruption with liquid nitrogen.

  • Subcellular fractionation: If AT4G33480 is localized to specific cellular compartments, consider fractionation protocols to enrich for those components.

  • Denaturation conditions: For Western blotting, protein samples from Arabidopsis histone preparations often require denaturation at 90°C for 2 minutes in SDS-PAGE buffer .

  • Protein quantification: Accurately quantify protein concentrations to ensure consistent loading.
    For reproducible results, document your extraction protocol carefully, noting buffer composition, tissue:buffer ratios, and extraction conditions .

How can I apply AT4G33480 antibody in multiplex immunofluorescence studies?

For multiplex immunofluorescence studies in plant tissues:

  • Antibody compatibility: Ensure primary antibodies are raised in different host species (e.g., rabbit anti-AT4G33480 combined with mouse anti-marker proteins) to allow simultaneous detection.

  • Fluorophore selection: Choose fluorophores with minimal spectral overlap for secondary antibodies.

  • Sample preparation: For Arabidopsis tissues, paraffin embedding followed by sectioning is commonly used for immunofluorescence microscopy. Fix tissues appropriately to preserve protein epitopes while maintaining tissue architecture .

  • Signal validation: Include single-stained controls to assess bleed-through between channels.

  • Image acquisition: Use sequential scanning if available to minimize crosstalk between fluorophores.
    Researchers have successfully used immunofluorescence microscopy on Arabidopsis inflorescence paraffin sections to localize specific proteins to particular cell layers , demonstrating the feasibility of this approach for studying protein localization in plant tissues.

Can AT4G33480 antibody be used in chromatin immunoprecipitation (ChIP) experiments?

If AT4G33480 is a chromatin-associated protein, ChIP may be applicable:

  • Cross-linking: For plant chromatin, typically use 1% formaldehyde for 10-15 minutes at room temperature under vacuum.

  • Chromatin fragmentation: Sonicate to achieve fragments between 200-500 bp.

  • Antibody amount: For ChIP applications with Arabidopsis proteins, approximately 6 μg of affinity-purified antibody is typically used per experiment .

  • Controls: Include a no-antibody control and, if available, a known target as positive control.

  • Data analysis: Design primers for both putative binding regions and negative control regions for qPCR analysis.
    Success in ChIP applications depends heavily on antibody quality and specificity. Validate your antibody thoroughly before proceeding with ChIP experiments .

What approaches can address weak or inconsistent AT4G33480 antibody signals?

When encountering weak or inconsistent signals:

  • Signal enhancement strategies:

    • Increase antibody concentration (but watch for increased background)

    • Extend primary antibody incubation time/temperature

    • Try alternative detection systems (e.g., switch from HRP to more sensitive detection methods)

    • Use signal amplification methods like tyramide signal amplification

  • Sample preparation optimization:

    • Modify extraction buffers to better preserve the protein

    • Adjust sample loading amount

    • Test different fixation protocols for IF/IHC

  • Antibody quality assessment:

    • Check antibody age and storage conditions

    • Consider testing a new lot or alternative clone

  • Statistical approach: Increase biological replicates and apply appropriate statistical analyses to account for variability
    Researchers working with plant antibodies have documented that signal quality can vary significantly based on sample preparation methods and antibody incubation conditions .

How can I distinguish specific from non-specific signals when using AT4G33480 antibody?

Distinguishing specific from non-specific signals requires multiple analytical approaches:

  • Molecular weight verification: Confirm that the detected band matches the expected molecular weight of AT4G33480.

  • Peptide competition: Pre-incubate the antibody with the immunizing peptide; specific signals should be blocked while non-specific signals persist.

  • Mutant/knockout comparison: Compare wild-type samples with those lacking or having reduced AT4G33480 expression; specific signals should be absent or reduced in these samples.

  • Cross-reactivity assessment: Test the antibody against related proteins or in different species to evaluate specificity.

  • Independent antibody validation: If available, compare results with a different antibody raised against a different epitope of AT4G33480.
    In protein chip technology applications, researchers have demonstrated that properly validated antibodies show high specificity for their target proteins without cross-reacting with other proteins, including those from the same protein family .

What factors might cause batch-to-batch variability in AT4G33480 antibody performance?

Batch-to-batch variability can stem from multiple sources:

  • Production variations:

    • Changes in immunization protocols

    • Differences in purification methods

    • Variations in antibody concentration or storage buffer

  • Storage and handling:

    • Improper storage temperature

    • Repeated freeze-thaw cycles

    • Inappropriate reconstitution methods

  • Documentation and quality control:

    • Request detailed QC data from suppliers

    • Maintain detailed records of antibody performance across batches

    • Consider developing internal validation protocols
      To mitigate variability, researchers should document antibody lot numbers, validate each new batch against previous batches, and maintain consistent experimental conditions .

How can I create a comprehensive validation dataset for AT4G33480 antibody?

Creating a robust validation dataset involves systematic characterization:

  • Multi-platform validation: Test the antibody in multiple applications (WB, IP, IF, ChIP) to establish a complete performance profile.

  • Epitope mapping: Identify the specific region of AT4G33480 recognized by the antibody.

  • Cross-reactivity profiling: Systematically test against related proteins and across multiple species.

  • Reproducibility assessment: Perform replicate experiments under varying conditions to establish robustness.

  • Standardized reporting: Document validation data in a standardized format, following guidelines like those established for antibody staining databases .
    Comprehensive antibody validation approaches, like those described for the development of antibody staining databases, demonstrate how systematic validation can ensure reliable and reproducible results across experiments .

Can AT4G33480 antibody be adapted for high-throughput screening approaches?

Adapting AT4G33480 antibody for high-throughput screening requires:

  • Antibody immobilization strategies for microarray or bead-based platforms

  • Assay miniaturization to reduce sample volume and antibody consumption

  • Automation compatibility for liquid handling and detection

  • Signal detection optimization for high sensitivity and reproducibility

  • Standardized analysis pipelines for data processing and interpretation
    Researchers have successfully implemented high-throughput antibody screening approaches using protein chips with Arabidopsis proteins. For example, a study generated Arabidopsis protein chips containing 96 different proteins and successfully demonstrated specific antibody binding without cross-reactivity to other proteins on the chip . Similar approaches could be adapted for AT4G33480 antibody in high-throughput applications.

How can AT4G33480 antibody be employed in multi-parameter analysis of plant stress responses?

For multi-parameter analysis:

  • Combinatorial experimental design: Integrate antibody-based detection with other analytical methods such as RNA-seq, metabolomics, or physiological measurements.

  • Temporal profiling: Collect samples across multiple time points following stress induction to track dynamic changes in protein expression.

  • Spatial analysis: Combine with tissue-specific sampling or in situ techniques to map protein expression across different plant tissues.

  • Quantitative analysis: Employ quantitative Western blotting or flow cytometry with appropriate standards and controls.

  • Data integration: Use computational approaches to integrate antibody-derived protein data with other -omics datasets.
    Advanced mass cytometry approaches used in immunological studies demonstrate how multi-parameter data can be collected and analyzed systematically , providing a model that could be adapted for plant biology research involving AT4G33480.

What are the considerations for developing custom AT4G33480 monoclonal antibodies for specialized applications?

Developing custom monoclonal antibodies requires careful planning:

  • Antigen design: Identify unique epitopes specific to AT4G33480 not present in related proteins.

  • Immunization strategy: Select appropriate host species and immunization protocol.

  • Screening methodology: Implement hierarchical screening approaches:

    • Initial ELISA screening for antibody production

    • Secondary screening for specificity

    • Tertiary functional assays for application-specific performance

  • Hybridoma selection and maintenance: Ensure stable cell lines and consistent production.

  • Validation pipeline: Establish comprehensive validation as described in section 4.3.
    Researchers have established successful strategies for screening monoclonal antibodies for Arabidopsis flowers, which could serve as a model for developing AT4G33480-specific antibodies. Their approach included initial Western blot screening followed by more detailed characterization of tissue specificity and subcellular localization, culminating in antigen identification via immunoprecipitation and mass spectrometry .

How might AT4G33480 antibody research benefit from emerging antibody engineering technologies?

Emerging technologies offer new possibilities:

  • Recombinant antibody development: Generation of recombinant antibody fragments with improved specificity and reduced background.

  • Multi-specific antibodies: Engineering bispecific or multispecific antibodies that can simultaneously detect AT4G33480 and interacting partners.

  • Antibody-enzyme fusion proteins: Creation of fusion proteins for direct detection without secondary reagents.

  • Nanobody development: Smaller antibody derivatives with improved tissue penetration for in situ applications.

  • Computationally designed antibodies: Application of structure-based computational approaches to optimize antibody-antigen interactions.
    Recent advances in antibody design demonstrated by DyAb sequence-based antibody design could potentially be applied to develop improved plant protein antibodies with enhanced affinity and specificity .

What are the potential applications of AT4G33480 antibody in studying plant-environment interactions?

AT4G33480 antibody could facilitate research in:

  • Stress response mechanisms: Track protein expression changes under various abiotic and biotic stresses.

  • Climate adaptation studies: Investigate protein regulation in response to temperature, water availability, or CO2 levels.

  • Developmental plasticity: Examine how environmental cues alter developmental programs at the protein level.

  • Inter-species interactions: Study protein expression changes during plant-microbe or plant-insect interactions.

  • Epigenetic regulation: If AT4G33480 has chromatin-associated functions, investigate environment-induced epigenetic modifications.
    The methodological approaches established for antibody-based detection in plant systems provide a foundation for applying AT4G33480 antibody research to these emerging areas of plant biology .

How can integrating computational approaches enhance AT4G33480 antibody-based research?

Computational integration offers several advantages:

  • Epitope prediction and antibody design: Use structural bioinformatics to predict optimal epitopes and design improved antibodies.

  • Image analysis automation: Develop machine learning algorithms for automated quantification of immunofluorescence or immunohistochemistry data.

  • Network biology integration: Place AT4G33480 in the context of interaction networks and signaling pathways.

  • Cross-species prediction: Predict potential cross-reactivity and conservation across plant species.

  • Data mining and meta-analysis: Extract patterns from published data to generate new hypotheses about AT4G33480 function.
    The standardized computational workflows established for antibody staining databases demonstrate how systematic data analysis can enhance the value of antibody-derived data , providing a model for computational integration in AT4G33480 research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.